Neurotransmitters are essential mediators of neuronal communication, governing neural circuit plasticity and maintaining cerebral functional homeostasis. They can be classified into major categories including monoamines, amino acids, acetylcholine, neuropeptides, purines, gaseous neurotransmitters, etc. Deciphering the dynamic fluctuations in neurotransmitter concentrations and distributions is paramount for elucidating fundamental neurophysiological processes and unraveling the mechanisms underpinning neuropathological conditions, such as Alzheimer's disease, Parkinson's disease, depression, etc. Fluorescence imaging technique employs specific probes that transduce the biochemical event of neurotransmitter recognition into a quantifiable optical signal, enabling non-invasive, highly specific visualization with high spatiotemporal resolution in live systems, representing an exceptionally promising class of tools for neurotransmitter detection. Owing to the compact size, excellent structural stability, high biocompatibility, tunable photophysical properties, and designable recognition mechanisms, organic small-molecule fluorescent probes act as ideal candidates for sensitive and selective neurochemical imaging. This review examines the advancements in the development and application of organic fluorescent probes for neurotransmitter detection, focusing on molecular designs, recognition principles (covalent or non-covalent interactions), signal transduction mechanisms (e.g., photoinduced electron transfer, intramolecular charge transfer, fluorescence resonance energy transfer), analytical performance, and their imaging capabilities in live cells, tissues, and in vivo models. A dedicated section provides a critical analysis of the prevailing limitations hindering broader application of current organic small-molecule fluorescent probes, such as challenges with reversibility, slow response times, photobleaching, limited multiplexing capability, insufficient blood-brain barrier penetration, and depth limitations in in vivo imaging. Building upon this assessment, we offer forward-looking perspectives on the future trajectory of fluorescent probe development. Key focus areas include engineering probes with enhanced binding kinetics and reversibility for real-time monitoring, superior photostability for longitudinal studies, capabilities for multiplexed analysis, ideal excitation/emission properties for deeper tissue penetration, and improved pharmacokinetic properties for efficient BBB crossing. This review aims to provide strategic design insights and a developmental roadmap for the next generation of high-performance neurochemical probes, thereby advancing fundamental neuroscience research and clinical diagnostic technologies.